Skip to content

Phase I clinical study of low-dose rate radiotherapy for the treatment of knee arthritis

Phase I clinical study of low-dose rate radiotherapy for the treatment of knee arthritis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111742
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Group A:Radiotherapy dose 0.5Gy/f
Group B:Radiotherapy dose 0.75Gy/f
Group C:Radiotherapy dose 1.0Gy/f

Sponsors

Yueyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age range: 40-75 years old; 2. Clarify inflammatory knee arthritis, including clear local inflammation on knee MRI or the possibility of extracting knee joint effusion; Elevated inflammatory indicators such as NE count, ESR, CRP, IL-6, etc. in blood/joint effusion tests; 3. KL score II-III KOA or VAS = 5 points; 4. NSAIDs are ineffective; 5.BMI<35kg/m²; 6. Medical history lasting for more than 3 months; 7. Overall good health condition; 8. Sign the informed consent form, have good compliance, and have family members cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. History of previous joint replacement, previous radiation therapy for affected joints, previous trauma, rheumatic disease, arterial or venous vascular disease, significant lymphedema, pregnancy or lactation, severe mental illness, and tumor history; 2. Researchers determine accompanying diseases that may affect the safety or completion of the study.

Design outcomes

Primary

MeasureTime frame
adverse events(AEs);

Secondary

MeasureTime frame
visual analogue scale(VAS);Range of motion scale;

Countries

china

Contacts

Public ContactWeng Jie

Yueyang Central Hospital

3173720582@qq.com+86 139 7507 0672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026